Episodes (Page 2)
✨
Annette Bakker and Andrew Lo discuss rescuing shelved drug candidates.
✨
Shannon Boye details Atsena Therapeutics' gene therapy for Stargardt.
✨
Kat Kozyrytska on technology's role in the biopharma ecosystem.
Kat Kozyrytska
✨
Aris Baras uses human genetics for discovering better drug targets.
✨
Matt Winton discusses late-stage development for dementia treatment.
Matt Winton
How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad
✨
Oren Gilad explains precision oncology and synthetic lethality.
Oren Gilad
✨
JJ You discusses how antibody design complexity impacts manufacturability.
Jhong-Jhe You
✨
Jeremy Levin addresses public distrust and politicization of science.
✨
Future CGT manufacturing trends include automated platforms and AI.
Omkar Kawalekar
Zoe Zheng
✨
CGT developers need transparency and data visibility from CDMOs.
Omkar Kawalekar
Zoe Zheng